148 related articles for article (PubMed ID: 9075017)
21. Magnetic resonance spectroscopy predicts outcomes for children with nonaccidental trauma.
Aaen GS; Holshouser BA; Sheridan C; Colbert C; McKenney M; Kido D; Ashwal S
Pediatrics; 2010 Feb; 125(2):295-303. PubMed ID: 20123781
[TBL] [Abstract][Full Text] [Related]
22. Regional brain chemical alterations in young children with autism spectrum disorder.
Friedman SD; Shaw DW; Artru AA; Richards TL; Gardner J; Dawson G; Posse S; Dager SR
Neurology; 2003 Jan; 60(1):100-7. PubMed ID: 12525726
[TBL] [Abstract][Full Text] [Related]
23. High-resolution magic angle spinning and 1H magnetic resonance spectroscopy reveal significantly altered neuronal metabolite profiles in CLN1 but not in CLN3.
Sitter B; Autti T; Tyynelä J; Sonnewald U; Bathen TF; Puranen J; Santavuori P; Haltia MJ; Paetau A; Polvikoski T; Gribbestad IS; Häkkinen AM
J Neurosci Res; 2004 Sep; 77(5):762-9. PubMed ID: 15352223
[TBL] [Abstract][Full Text] [Related]
24. Lower concentration of hippocampal N-acetylaspartate in familial bipolar I disorder.
Deicken RF; Pegues MP; Anzalone S; Feiwell R; Soher B
Am J Psychiatry; 2003 May; 160(5):873-82. PubMed ID: 12727690
[TBL] [Abstract][Full Text] [Related]
25. Cerebral metabolites in patients with acute and subacute strokes: concentrations determined by quantitative proton MR spectroscopy.
Mathews VP; Barker PB; Blackband SJ; Chatham JC; Bryan RN
AJR Am J Roentgenol; 1995 Sep; 165(3):633-8. PubMed ID: 7645484
[TBL] [Abstract][Full Text] [Related]
26. Proton magnetic resonance spectroscopy of pediatric brain tumors.
Sutton LN; Wang Z; Gusnard D; Lange B; Perilongo G; Bogdan AR; Detre JA; Rorke L; Zimmerman RA
Neurosurgery; 1992 Aug; 31(2):195-202. PubMed ID: 1513425
[TBL] [Abstract][Full Text] [Related]
27. Diffuse neuroaxonal involvement in mucolipidosis IV as assessed by proton magnetic resonance spectroscopic imaging.
Bonavita S; Virta A; Jeffries N; Goldin E; Tedeschi G; Schiffmann R
J Child Neurol; 2003 Jul; 18(7):443-9. PubMed ID: 12940649
[TBL] [Abstract][Full Text] [Related]
28. Proton magnetic resonance spectroscopy in an Italian family with spinocerebellar ataxia type 1.
Mascalchi M; Tosetti M; Plasmati R; Bianchi MC; Tessa C; Salvi F; Frontali M; Valzania F; Bartolozzi C; Tassinari CA
Ann Neurol; 1998 Feb; 43(2):244-52. PubMed ID: 9485066
[TBL] [Abstract][Full Text] [Related]
29. Reduced concentrations of thalamic N-acetylaspartate in male patients with schizophrenia.
Deicken RF; Johnson C; Eliaz Y; Schuff N
Am J Psychiatry; 2000 Apr; 157(4):644-7. PubMed ID: 10739431
[TBL] [Abstract][Full Text] [Related]
30. Metabolic change in the right dorsolateral prefrontal cortex and its correlation with symptom severity in patients with generalized anxiety disorder: Proton magnetic resonance spectroscopy at 3 Tesla.
Moon CM; Kang HK; Jeong GW
Psychiatry Clin Neurosci; 2015 Jul; 69(7):422-30. PubMed ID: 25611853
[TBL] [Abstract][Full Text] [Related]
31. Comparisons of brain metabolites observed by HRMAS 1H NMR of intact tissue and solution 1H NMR of tissue extracts in SIV-infected macaques.
Ratai EM; Pilkenton S; Lentz MR; Greco JB; Fuller RA; Kim JP; He J; Cheng LL; González RG
NMR Biomed; 2005 Jun; 18(4):242-51. PubMed ID: 15759297
[TBL] [Abstract][Full Text] [Related]
32. Temporal lobe epilepsy: bilateral hippocampal metabolite changes revealed at proton MR spectroscopic imaging.
Ende GR; Laxer KD; Knowlton RC; Matson GB; Schuff N; Fein G; Weiner MW
Radiology; 1997 Mar; 202(3):809-17. PubMed ID: 9051038
[TBL] [Abstract][Full Text] [Related]
33. Alterations of brain metabolites in metachromatic leukodystrophy as detected by localized proton magnetic resonance spectroscopy in vivo.
Kruse B; Hanefeld F; Christen HJ; Bruhn H; Michaelis T; Hänicke W; Frahm J
J Neurol; 1993 Dec; 241(2):68-74. PubMed ID: 7908027
[TBL] [Abstract][Full Text] [Related]
34. Comparative study of cerebral white matter in autism and attention-deficit/hyperactivity disorder by means of magnetic resonance spectroscopy.
Fayed N; Modrego PJ
Acad Radiol; 2005 May; 12(5):566-9. PubMed ID: 15866128
[TBL] [Abstract][Full Text] [Related]
35. Use of localized proton nuclear magnetic resonance spectroscopy in Canavan's disease.
Aydinli N; Calişkan M; Calay M; Ozmen M
Turk J Pediatr; 1998; 40(4):549-57. PubMed ID: 10028864
[TBL] [Abstract][Full Text] [Related]
36. Multivoxel proton magnetic resonance spectroscopy in heat stroke.
Li J; Zhang XY; Wang B; Zou ZM; Li HF; Wang PY; Xia JK
Clin Radiol; 2015 Jan; 70(1):37-41. PubMed ID: 25443777
[TBL] [Abstract][Full Text] [Related]
37. Metabolic changes in the vicinity of brain contusions: a proton magnetic resonance spectroscopy and histology study.
Schuhmann MU; Stiller D; Skardelly M; Bernarding J; Klinge PM; Samii A; Samii M; Brinker T
J Neurotrauma; 2003 Aug; 20(8):725-43. PubMed ID: 12965052
[TBL] [Abstract][Full Text] [Related]
38. Altered chemical metabolites in the amygdala-hippocampus region contribute to autistic symptoms of autism spectrum disorders.
Endo T; Shioiri T; Kitamura H; Kimura T; Endo S; Masuzawa N; Someya T
Biol Psychiatry; 2007 Nov; 62(9):1030-7. PubMed ID: 17631869
[TBL] [Abstract][Full Text] [Related]
39. Brain metabolite levels assessed by lactate-edited MR spectroscopy in premature neonates with and without pentobarbital sedation.
Wang ZJ; Vigneron DB; Miller SP; Mukherjee P; Charlton NN; Lu Y; Barkovich AJ
AJNR Am J Neuroradiol; 2008 Apr; 29(4):798-801. PubMed ID: 18184837
[TBL] [Abstract][Full Text] [Related]
40. Proton magnetic resonance spectroscopy in disturbances of cortical development.
Kaminaga T; Kobayashi M; Abe T
Neuroradiology; 2001 Jul; 43(7):575-80. PubMed ID: 11512591
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
